Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol add-on treatment for obsessive-compulsive disorder
RBR-467ksmbPhase 3Recruiting
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cannabidiol in obsessive compulsive disorder (OCD), sponsored by Faculdade de Medicina de Ribeirão Preto. Started Jan 2021; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on RBR-467ksmb.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-467ksmb.